Literature DB >> 9426231

Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1.

R Evers1, N H Cnubben, J Wijnholds, L van Deemter, P J van Bladeren, P Borst.   

Abstract

The human multidrug resistance protein MRP1 mediates transport of organic substrates conjugated to glutathione, glucuronide, or sulfate. The naturally occurring prostaglandins A1 and A2 can form two diastereomeric glutathione S-conjugates, and it has been speculated that these might be substrates for MRP1. Here we present evidence that polarized MDCKII cells expressing MRP1 cDNA transport PGA1-GS to the basolateral side of a cell monolayer, in accordance with the lateral localization of human MRP1 in these cells. Furthermore, we show that vesicles made from yeast cells expressing MRP1 cDNA and from mouse erythrocytes (known to contain mrpl) actively accumulate both diastereomers of PGA2-GS with a similar efficiency. Recently, we generated mice with a homozygous mutant mrp1 allele. Uptake of PGA2-GS in vesicles made from erythrocytes of these mice was 3.2 times lower than in wild-type vesicles, but was still significantly above background. This residual transport activity was partly inhibited by methotrexate and cAMP, whereas mrp1-mediated activity was unaffected by these compounds. We conclude that mouse erythrocytes contain at least two transport systems for PGA2-GS. One of these is mrp1; the other one has not been identified yet, but can be inhibited by methotrexate and cAMP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426231     DOI: 10.1016/s0014-5793(97)01442-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  30 in total

1.  Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.

Authors:  Kazutoshi Horie; Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

2.  Interaction potential of etravirine with drug transporters assessed in vitro.

Authors:  Nadine Cécile Luise Zembruski; Walter Emil Haefeli; Johanna Weiss
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

3.  Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir.

Authors:  R A B van Waterschoot; R ter Heine; E Wagenaar; C M M van der Kruijssen; R W Rooswinkel; A D R Huitema; J H Beijnen; A H Schinkel
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Influence of passive permeability on apparent P-glycoprotein kinetics.

Authors:  K A Lentz; J W Polli; S A Wring; J E Humphreys; J E Polli
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

5.  The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs.

Authors:  Glen Reid; Peter Wielinga; Noam Zelcer; Ingrid van der Heijden; Annemieke Kuil; Marcel de Haas; Jan Wijnholds; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-30       Impact factor: 11.205

6.  Anti-cancer-prostaglandin-induced cell-cycle arrest and its modulation by an inhibitor of the ATP-dependent glutathione S-conjugate export pump (GS-X pump).

Authors:  T Ishikawa; K Akimaru; M Nakanishi; K Tomokiyo; K Furuta; M Suzuki; R Noyori
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

7.  Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor.

Authors:  Sheetal Agarwal; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2007-03-06       Impact factor: 5.875

8.  Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?

Authors:  Fuxing Tang; Kazutoshi Horie; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

9.  Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.

Authors:  Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

10.  Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.

Authors:  Fuxing Tang; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.